MedPath

Endoscopic Treatment of Recurrent Upper GI Bleeding: OTSC [Over the Scope Clip] Versus Standard Therapy

Not Applicable
Conditions
Acute Upper Gastrointestinal Hemorrhage
Interventions
Device: Endoscopic hemostasis
Registration Number
NCT01836900
Lead Sponsor
Kliniken Ludwigsburg-Bietigheim gGmbH
Brief Summary

Prospective-randomized trial. Patients with recurrent bleeding from gastroduodenal ulcers are randomized into either endoscopic treatment with the OTSC \[Over The Scope Clip\] or endoscopic standard therapy. Hypothesis: Endoscopic therapy with OTSC is superior to standard therapy regarding technical success and rebleeding.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Recurrence of bleeding from gastroduodenal ulcers
Exclusion Criteria
  • Malignant ulcers, variceal bleeding, patients younger than 18 years, lesions not suitable for treatment with OTSC

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Standard TherapyEndoscopic hemostasisEndoscopic therapy with Standard Clip + injection of epinephrine solution or thermal therapy + injection of epinephrin-solution
OTSC (Over The Scope Clip)Endoscopic hemostasisEndoscopic therapy with Application of OTSC Clip and Injection of epinephrin-solution
Primary Outcome Measures
NameTimeMethod
Persistent bleeding or Rebleeding with 7 days7 days
Secondary Outcome Measures
NameTimeMethod
Amount of endoscopic reinterventions7 d
blood units transfused30 days
duration of hospital stay30 days
duration of intensive care unit stay30 days
30 d Mortality30 days
Necessity of surgical or angiographic therapy7 d
Complications during or after OTSC (Over The Scope Clip) placement7 d

Trial Locations

Locations (1)

Klinikum Ludwigsburg

🇩🇪

Ludwigsburg, Germany

© Copyright 2025. All Rights Reserved by MedPath